HUNTINGTON BEACH, CA / ACCESSWIRE / June 22, 2015 / Greenway Designs, Inc., (PINKSHEETS: GDGI), announced today that it will from a subsidiary to serve the Cannabis Industry with its newly acquired Cannabis-Related assets. These assets acquired in the Deal-X Technologies acquisition include: Cannabis-Related Intellectual Property, Information Technology, Daily Deal and Digital Coupon Technologies and Trademarks. The subsidiary will use these assets to serve nearly every aspect of the Cannabis Industry.

“With the help of a Cannabis Industry veteran we were able to identify tremendous opportunities for Greenway Designs as well as the value of these Cannabis-Related Assets and we will always be appreciative of that help,” said Ben Lefrancois, CEO of Greenway Design Group, Inc.

Deal-X Technologies is a proprietary “Digital Coupon” and “Daily Deal” software platform for local commerce and national ecommerce (online sales). Deal-X Technologies’ website is www.Deal-X.com.

About Greenway Design Group, Inc.

Greenway Design Group, Inc. is a green technologies company aggressively pursuing business opportunities to increase shareholders value.

Safe Harbor

This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with OTC Markets, Inc.’s OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Ben Lefrancois
800-399-6158
ben@greenwaydesigns.com

SOURCE: Greenway Designs, Inc.

ReleaseID: 430044

DENVER, CO / ACCESSWIRE / June 22, 2015 / Midway Gold Corp. (TSX and NYSE-MKT: MDW) (the “Company” or “Midway”) received notice from the NYSE MKT LLC (the “NYSE MKT”) indicating that the NYSE MKT has suspended the Company’s common stock from trading immediately and determined to commence proceedings to delist the Company’s common stock pursuant to Section 1003(c)(iii) of the NYSE MKT LLC Company Guide. The NYSE MKT’s determination was based on the previously disclosed Chapter 11 bankruptcy filings by the Company and certain of its domestic direct and indirect subsidiaries. Also on June 22, 2015, the Toronto Stock Exchange (“TSX”) suspended the Company’s common stock from trading immediately while the TSX reviews the Company’s continued eligibility for listing under the TSX’s Expedited Review Process. The suspension and possible delisting are based on the Chapter 11 bankruptcy filings of the Company and certain of its direct and indirect subsidiaries, the Company’s financial condition and/or operating results, and whether the Company has adequate working capital and appropriate capital structure. A hearing to decide whether to delist the Company’s securities from the TSX is currently scheduled for June 25, 2015.

The Company does not intend to take any further action to appeal these decisions, and therefore it is expected that the common stock will be delisted from both the NYSE MKT and the TSX following completion of their proceedings.

Also effective today, the current Chairman of the Board of Directors of the Company, Timothy J. Haddon, has resigned from the Board of Directors for personal reasons. The Board of Directors wishes to thank Mr. Haddon for his services.

Midway Gold Corp.
Investor Relations phone: 720-979-0900
www.midwaygold.com

Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the NYSE MKT accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements about the Company and its business. Forward looking statements are statements that are not historical facts and include, but are not limited to, statements about future exchange decisions, appeal and other statements, estimates and expectations. Forward-looking statements are typically identified by words such as: “plan”, “expect”, “anticipate”, “intend”, “estimate”, “budgeted” and similar expressions or the negative of such expressions or which by their nature refer to future events. The forward-looking statements in this press release are subject to various risks, uncertainties and other factors that could cause the Company’s actual results or achievements to differ materially from those expressed in or implied by forward looking statements. These risks, uncertainties and other factors include, without limitation, risks related to the timing and completion of the Company’s intended work plans, risks related to fluctuations in gold prices; uncertainties related to raising sufficient financing to fund the planned work in a timely manner and on acceptable terms; changes in planned work resulting from weather, logistical, technical or other factors; the possibility that results of work will not fulfill expectations and realize the perceived potential of the Company’s properties; uncertainties involved in the interpretation of drilling results, modelling, engineering and other analysis; risk of inaccurate estimation of gold resources and reserves; the possibility that the estimated recovery rates and grades may not be achieved as modelled or projected; the possibility that capital and operating costs may be higher than currently estimated and may render operations uneconomic; risk of accidents, equipment breakdowns and labor disputes or other unanticipated difficulties or interruptions; the possibility of cost overruns or unanticipated expenses in the work program; inherent, unanticipated and unknown risks associated with production activities; the possibility that required permits may not be obtained on a timely manner or at all; changes in interest and currency exchanges rates; local and community impacts and issues; environmental costs and risks; and other factors identified in the Company’s SEC filings and its filings with Canadian securities regulatory authorities. Forward-looking statements are based on the beliefs, opinions and expectations of the Company’s management at the time they are made, and other than as required by applicable securities laws, the Company does not assume any obligation to update its forward-looking statements if those beliefs, opinions or expectations, or other circumstances, should change. Although the Company believes that such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. For the reasons set forth above, investors should not attribute undue certainty to or place undue reliance on forward-looking statements.

SOURCE: Midway Gold Corp.

ReleaseID: 430042

VANCOUVER, BC / ACCESSWIRE / June 22, 2015 / TURQUOISE CAPITAL CORP. (TSXV: TQC.P) (“Turquoise“), a capital pool company, announces that it has amended the terms of its proposed brokered offering (see news release dated April 2, 2015), by way of TSX Venture Exchange (the “Exchange”) Short Form Offering Document, (the “Offering”) to be 5,714,285 units (each a “Unit”) of Turquoise at a price of $0.35 per Unit for gross proceeds of $2,000,000. Previously, the Offering consisted of a minimum of 4,285,715 Units and up to a maximum of 5,714,285 Units for minimum gross proceeds of $1,500,000 and up to a maximum of $2,000,000.

Each Unit will continue to consist of one post-consolidation common share of Turquoise and one-half of one share purchase warrant (each a “Warrant”), with each whole Warrant entitling the holder an additional post-consolidation common share of Turquoise at a price of $0.60 per post-consolidation common share for a period of 36 months from the closing date of the Offering. Turquoise will have the right to accelerate the expiry date of the Warrants if, at any time, the closing price of Turquoise’s common shares is equal to, or greater than $0.70 for 15 consecutive trading days after the date that is four months and a day following the closing of the Offering. In the event of acceleration, the expiry date will be accelerated to a date that is 30 days after the date Turquoise gives notice to the Warrant holders that it has elected to exercise this acceleration right.

Wolverton Securities Ltd. (“Wolverton”) has agreed to act as lead agent for the Offering and will receive a commission equal to 10% of the gross proceeds of any Units sold under the Offering. At the option of Wolverton, the commission may be paid in cash or by the issuance of Units or a combination thereof. Wolverton will also be granted non-transferable option (the “Agent’s Option”) to purchase up to 10% of the number of Units sold under the Offering at an exercise price of $0.35 per Unit for a period of 5 years from the date of closing of the Offering. Each Unit will consist of one post-Consolidation common share of Turquoise and one-half of one non-transferable share purchase warrant (an “Agent Warrant”). The Agent’s Warrants will be on the same terms as the Warrants. In addition, Wolverton will also receive a corporate finance fee of $30,000 plus GST (the “Corporate Finance Fee”), of which $15,000 has been paid. At the option of Wolverton, the balance of the Corporate Finance Fee may be paid in cash or by the issuance of Units or a combination thereof. Also, Turquoise has agreed to pay the expenses reasonably incurred by Wolverton in connection with the Offering.

The Offering is to be completed in conjunction with Turquoise’s proposed Qualifying Transaction (the “Transaction”) with Vigil Technologies Inc. (“Vigil”). The proceeds of the Offering will be used to fund the development and marketing of Vigil’s wireless sensor network and general working capital purposes.

Amendment to the Non-Brokered Private Placement Offering

Turquoise also announces that the non-brokered private placement offering (the “Vigil Financing”) of Vigil Technologies Inc. (“Vigil”) will now be up to 2,142,857 units at a price of $0.35 per unit for gross proceeds of up to $750,000 instead of the previously announced minimum of 2,142,857 units for gross proceeds of $750,000.

Under the Vigil Financing, each unit will continue to consist of one common share of Vigil and one share purchase warrant, with each share purchase warrant entitling the holder to purchase an additional common share of Vigil at a price of $0.60 per share for a period of three years from the date of issue, subject to a right of acceleration (which is on the same terms as the warrants issued under the Exchange Short Form Offering Document). Vigil will pay a finder’s fee of up to 10% of the gross proceeds of the offering and issue finders’ options up to 10% of the number of units sold under the offering.

Proceeds of the Vigil Financing will be used for product development and research & development of Vigil’s sensor technology, expenses incurred under the Transaction and general working capital purposes.

About Vigil Technologies Inc.

Vigil was incorporated on June 4, 2010 under the laws of the province of British Columbia. Vigil is a research and development company specializing in the development of wireless sensor networks for security and life safety applications.

About Turquoise

Turquoise was incorporated November 14, 2012 under the Business Corporations Act (British Columbia). Turquoise is a CPC as defined by the CPC Policy. On June 28, 2013, Turquoise completed its initial public offering and its common shares were listed for trading on the Exchange on July 3, 2013. As disclosed in its final prospectus dated April 15, 2013, Turquoise’s business has been restricted to the identification and evaluation of businesses or assets for the purpose of completing its Qualifying Transaction.

For further information please contact:

Turquoise Capital Corp.
John Da Costa, CFO
(604) 648-0516

Information set forth in this news release contains forward-looking statements. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. Turquoise cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Turquoise‘s control. Such factors include, among other things: risks and uncertainties relating to Turquoise‘s ability to complete the proposed Transaction; and other risks and uncertainties, including those described in Turquoise‘s Prospectus dated April 15, 2013 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Turquoise undertakes no obligation to publicly update or revise forward-looking information.

Completion of the Transaction is subject to a number of conditions, including but not limited to, Exchange acceptance and if applicable pursuant to Exchange Requirements, majority of the minority shareholder approval. Where applicable, the Transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the Transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed Transaction and has neither approved nor disapproved the contents of this press release.

A halt in trading shall remain in place until after the Transaction is completed or such time that acceptable documentation is filed with the TSX Venture Exchange.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Turquoise Capital Corp.

ReleaseID: 430038

TORONTO, ON / ACCESSWIRE / June 22, 2015 / The Canadian Bioceutical Corporation (“BCC“) (TSX Venture: BCC.V) announces today that it closed a second and final tranche of private placement equity financing in the amount of $35,000 through the issuance of 100,000 common shares at a price of $0.35 per share. No commission is payable in relation thereto.

The initial tranche of this private placement received the final approval of the TSX Venture Exchange on June 4, 2015 and details thereof are included in BCC’s News Release of the same date. In such tranche, $342,500 was raised through the issuance of 978,572 common shares.

As announced on May 4, 2015, it is anticipated that the gross proceeds of the Private Placement will be used as to seventy percent (70%) allocated to fund BCC’s plans to expand its existing life sciences business into the production, processing and distribution of medical marijuana and cannabis-based medicinal products (including in relation to the build out of the manufacturing facility located in the City of Owen Sound, Ontario) and thirty percent (30%) allocated for general working capital purposes.

Additional details in relation to BCC’s plan to enter into the medical marijuana sector may be found in the company’s two (2) News Releases of January 7, 2015 with the most recent update provided in BCC’s News Release of May 11, 2015.

All securities issued pursuant to this tranche will be subject to a hold period that will extend a minimum of four (4) months subsequent to the closing of this tranche.

Upon the closing of this tranche, BCC would have 39,229,553 issued and outstanding common shares, 15,846,115 common share purchase warrants and 3,032,000 incentive stock options.

About The Canadian Bioceutical Corporation

BCC, formerly Allegiance Equity Corporation, is an Ontario corporation that, for over two decades has been developing unique standardized mass-market nutraceutical products for the treatment of common ailments where present pharmaceutical treatments and over-the-counter products fail to meet the needs of patients. BCC has targeted markets having clearly identified product deficiencies and dissatisfied consumers afflicted with a variety of medical conditions. BCC obtains regulatory approval and patents for these unique compounds and formulations and may produce and distribute or license its products for royalty revenues.

BCC’s principal brands are CinG-X(TM), Reliéva(TM) and FertaMax(TM). The company, through its subsidiary, BioCannabis Products Ltd., and subsequent to receiving its MMPR license from Health Canada and the potential revision of these regulations, intends to develop and market a series of new cannabis-based branded medicinal products to address this rapidly-evolving market.

CSA Investor Caution

Investors should be aware that companies cannot legally conduct a medical marijuana business without a license from Health Canada and that there is significant time and cost required to obtain such a license. As a publicly-traded company publicizing its intention to enter the medical marijuana industry, BCC urges potential investors in any company in this sector, to become familiar with the required resources and the related risks, costs implications and time required before a company will be able to begin licensed operations. There is no assurance that any company announcing its intent to enter the medical marijuana industry will be successful in obtaining a license or in creating shareholder value.

Cautionary Statement Regarding Forward-Looking Information

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the Transaction and BCC’s objectives and intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in BCC’s public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although BCC believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, BCC disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the Policies of the Exchange) accepts responsibility of the adequacy or accuracy of this release.

For further information please contact:

Scott Boyes, President and CEO 
scott@canadianbioceutical.com
(416) 840-4703

SOURCE: The Canadian Bioceutical Corporation

ReleaseID: 430034